Recent Updates
Recently added Catalysts

Oxytocin

Phase 1

Oxytocin Effect on Memory Performance During Phase 1 | Small molecule | Other |China Pharma Holdings, Inc.|Last Updated: Oct 15, 2018

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindPLACEBO_CONTROLLED
Total Trials1
Total Enrollment224
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT02745522Can Oxytocin Enhance the Placebo Effect?PHASE1 COMPLETED 224Dec 1, 2015Aug 1, 2017Oct 15, 20181 China
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Memory performance in different phases
1 hour

N-back memory performance (accuracy) was included into analysis.

Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingDOUBLE
ModelPARALLEL
PurposeBASIC_SCIENCE
Treatment Arms
ArmTypeDescription
OxytocinEXPERIMENTALOxytocin nasal spray
PlaceboPLACEBO_COMPARATORPlacebo nasal spray
Interventions
NameTypeDescription
OxytocinDRUG -
PlaceboDRUG -
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 30 Years
SexMALE
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Healthy subjects without past or current psychiatric or neurological disorder Exclusion Criteria: * history of head injury; * claustrophobia; * medical or psychiatric illness.

Countries:China
Unlock Eligibility Criteria